Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-118169

Chief Operating Officer gave up 6,250 shares (to pay taxes)

  • Chief Operating Officer acquired 12,305 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BILINSKY IGOR · Chief Operating Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-01 Exercise or conversion : show line 1 in the form +8,789 108,478 D
2025-12-01 Shares withheld for taxes : show line 2 in the form −4,464 $2.23 $9,955 104,014 D
2025-12-02 Exercise or conversion : show line 3 in the form +3,516 107,530 D
2025-12-02 Shares withheld for taxes : show line 4 in the form −1,786 $2.14 $3,822 105,744 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-01 Exercise or conversion : show line 5 in the form Restricted Stock Units −8,789 43,949 D
2025-12-02 Exercise or conversion : show line 6 in the form Restricted Stock Units −3,516 3,517 D
Loading xslF345X05/tm2532666-3_4seq1.xml…